Aetna Inc. (NYSE:AET) – Stock analysts at Leerink Swann lowered their FY2018 earnings per share (EPS) estimates for shares of Aetna in a research note issued to investors on Tuesday. Leerink Swann analyst A. Gupte now expects that the company will post earnings per share of $9.90 for the year, down from their prior estimate of $10.10.

AET has been the topic of a number of other research reports. Wells Fargo & Company reissued an “outperform” rating and set a $208.00 price objective (up previously from $200.00) on shares of Aetna in a research report on Monday. Credit Suisse Group began coverage on shares of Aetna in a report on Thursday, November 2nd. They issued a “neutral” rating and a $174.00 target price on the stock. Zacks Investment Research lowered shares of Aetna from a “buy” rating to a “hold” rating in a report on Monday, October 16th. Cantor Fitzgerald restated an “overweight” rating and issued a $175.00 target price (up previously from $150.00) on shares of Aetna in a report on Wednesday, August 9th. Finally, Raymond James Financial upgraded shares of Aetna from a “market perform” rating to an “outperform” rating and set a $200.00 target price on the stock in a report on Friday, November 3rd. Twelve research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $175.19.

Aetna (NYSE AET) traded down $0.07 during mid-day trading on Wednesday, hitting $178.83. 4,485,753 shares of the stock were exchanged, compared to its average volume of 2,588,375. The company has a market cap of $58,283.73, a PE ratio of 17.50, a PEG ratio of 1.63 and a beta of 0.61. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 0.52. Aetna has a one year low of $116.04 and a one year high of $192.37.

Aetna (NYSE:AET) last released its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.06 by $0.39. The company had revenue of $14.99 billion for the quarter, compared to analysts’ expectations of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The business’s revenue was down 5.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.07 EPS.

Several hedge funds have recently modified their holdings of the company. Wedbush Securities Inc. increased its stake in shares of Aetna by 1.4% during the 2nd quarter. Wedbush Securities Inc. now owns 3,779 shares of the company’s stock worth $574,000 after purchasing an additional 52 shares during the last quarter. Calamos Wealth Management LLC increased its stake in shares of Aetna by 0.7% during the 2nd quarter. Calamos Wealth Management LLC now owns 8,919 shares of the company’s stock worth $1,354,000 after purchasing an additional 65 shares during the last quarter. Sigma Planning Corp increased its stake in shares of Aetna by 2.6% during the 2nd quarter. Sigma Planning Corp now owns 2,702 shares of the company’s stock worth $410,000 after purchasing an additional 69 shares during the last quarter. UMB Bank N A MO increased its stake in shares of Aetna by 1.0% during the 2nd quarter. UMB Bank N A MO now owns 7,601 shares of the company’s stock worth $1,154,000 after purchasing an additional 74 shares during the last quarter. Finally, FCA Corp TX increased its stake in shares of Aetna by 0.7% during the 2nd quarter. FCA Corp TX now owns 12,230 shares of the company’s stock worth $1,857,000 after purchasing an additional 80 shares during the last quarter. Institutional investors own 88.03% of the company’s stock.

In other Aetna news, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $162.85, for a total value of $1,675,400.80. Following the completion of the sale, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,465,734.55. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, President Karen S. Lynch sold 15,271 shares of the firm’s stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the sale, the president now owns 64,261 shares of the company’s stock, valued at approximately $10,404,498.51. The disclosure for this sale can be found here. Company insiders own 0.90% of the company’s stock.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Thursday, January 11th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Wednesday, January 10th. This represents a $2.00 annualized dividend and a yield of 1.12%. Aetna’s dividend payout ratio (DPR) is 37.04%.

COPYRIGHT VIOLATION NOTICE: This article was originally published by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at https://www.dailypolitical.com/2017/12/07/aetna-inc-to-post-fy2018-earnings-of-9-90-per-share-leerink-swann-forecasts-aet.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Earnings History and Estimates for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.